Adherence to treatment in inflammatory bowel disease;Adhesión al tratamiento en la enfermedad inflamatoria intestinal

Revista Espanola de Enfermedades Digestivas

Volumn 97, Issue 4, 2005, Pages 249-257

  López San Román, Antonio ^a   Bermejo, F ^b   Carrera, E ^a   Perez Abad M ^a   Boixeda, D ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

Author keywords

Adherence to treatment; Inflammatory bowel disease; Treatment

Indexed keywords

MESALAZINE; SALICYLIC ACID DERIVATIVE;

ADULT; ARTICLE; CHRONICITY; CLINICAL ARTICLE; CORRELATION ANALYSIS; CROHN DISEASE; DATA ANALYSIS; DEPRESSION; DOCTOR PATIENT RELATION; DRUG URINE LEVEL; ENTERITIS; FEMALE; HUMAN; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; SCORING SYSTEM; SELF REPORT; SOCIAL STATUS; TREATMENT REFUSAL; TRUST;

EID: 19944403275     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082005000400005     Document Type: Article

References (20)

1. Sewitch MJ, Abrahamowicz M, Barkun A, Bitton A, Wild GE, Cohen A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003; 98: 1535-44.
2. Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Medicine 2003; 114: 39-43
3. Dracup K, Baker DW, Dunbar SB, Dacey RA, Brooks NH, Johnson JC, et al. Management of heart failure. II. Counseling, education, and lifestyle modifications. JAMA 1994; 272: 1442-6.
4. a edición. Madrid: Espasa Calpe, 2001.
5. Farup PG, Hovde O, Halvorsen FA, Raknerud N, Brodin U. Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens. Scand J Gastroenterol 1995; 30: 164-70.
6. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980; 1: 514.
7. Lichtiger SC, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G. Cyclosporin in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330: 1841-5.
8. Tejero A, Guimerá EM, Farré JM, Peri JM. Uso clínico del HAD (Hospital Anxiety and Depression Scale) en población psiquiátrica. Un estudio de su sensibilidad, fiabilidad y validez. Rev Depto Psiquiatría Facultad Med Barna 1986; 13: 233-8.
9. Lopez-Vivancos J, Casellas F, Badia X, Vilaseca J, Malagelada JR. Validation of the Spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn's disease. Digestion 1999; 60 (3): 274-80.
10. Shaw IS, Jobson BA, Silverman D, Ford J, Hearing SD, Ball D, et al. Is your patient taking the medicine? A simple assay to measure compliance with 5-aminosalicylic acid-containing compounds. Aliment Pharmaeol Ther 2002; 16: 2053-9.
11. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med 2004; 164: 722-32.
12. Pasternak RC. Report of the Adult Treatment Panel III: the 2001 National Cholesterol Education Program guidelines on the detection, evaluation and treatment of elevated cholesterol in adults. Cardiol Clin 2003; 21: 393-8.
13. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42: 200-9.
14. Sánchez-Arcilla I, Vílchez JM, García de la Torre M, Fernández X, Noguerado A. Infección tuberculosa latente en población indigente. Comparación de dos pautas terapéuticas. Med Clin (Barc) 2004; 122: 57-9.
15. Jasmer RM, Nahid P, Hopewell PC. Latent tuberculosis infection. New England J Med 2002; 347: 1860-6.
16. Levy RL, Feld AD. Increasing patient adherence to gastroenterology treatment and prevention regimens. Am J Gastroenterol 1999; 94: 1733-42.
17. Van Hees PA, van Tongeren JH. Compliance to therapy in patients on a maintenance dose of sulfasalazine. J Clin Gastroenterol 1982; 4: 333-6.
18. Shale MJ, Riley SA. Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18: 191-8.
19. Kane SV, Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 2001; 96: 2929-33.
20. Casellas F, Fontanet G, Borruel N, Malgelada JR. Opinión de los pacientes con enfermedad inflamatoria intestinal sobre la atención sanitaria recibida. Rev Esp Enferm Dig 2004; 96: 174-84.